A Single Dose Bioequivalence Study OfTwo Formulations Of Nicotine Lozenges

NCT00651352 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer Smokers

Interventions

DRUG: 4 mg nicotine lozenge
DRUG: 2 mg nicotine lozenge
DRUG: 2 mg nicotine prototype
DRUG: 4 mg nicotine prototype

Sponsor

GlaxoSmithKline